Table 2:
Pathological Diagnosis | Genetic Diagnosis | Number affected |
---|---|---|
Tubulointerstitial Kidney Disease (n=18) | MUC1 | 6 (34%) |
UMOD | 4 (22%) | |
HNF1B | 1 (5.5%) | |
NPHP 1 | 1 (5.5%) | |
IFT140 | 1 (5.5%) | |
No diagnosis | 5 (27.5%) | |
Chronic Glomerulonephritis (n = 15) | COL4A5 | 2 (13%) |
UMOD | 1 (7%) | |
MUC1 | 1 (7%) | |
No Diagnosis | 11 (73%) | |
Focal Segmental Glomerulosclerosis/Alport Syndrome (n=11) | COL4A5 | 5 (45%) |
FANCI | 1 (10%) | |
No Diagnosis | 5(45%) | |
Thrombotic Microangiopathy (n=17) | UMOD | 2 (11.5%) |
HNF1B | 2 (11.5%) | |
MUC1 | 1 (6%) | |
INF2 | 4 (24%) | |
IFT140 | 1 (6%) | |
No Diagnosis | 7 (41%) | |
Non-specific causes (n=14) | COL4A5 | 1 (7%) |
C3 | 1 (7%) | |
WNK4 | 1 (7%) | |
SLC3A1 | 1 (7%) | |
HNF1B | 1 (7%) | |
INF2 | 1 (7%) | |
No Diagnosis | 8 (58%) |